Showing results (21-30 of 778) with videos related to
Sort By:
Pageof 78
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 4, 2010
Clinical predictors of response to cetuximab-chemotherapy in metastatic colorectal cancerAda T W Ma, Brigette B Y Ma, Kenny I K Lei, et al.Scientific Reports|May 24, 2018
Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinomaChi-Hang Wong, Brigette B Y Ma, Connie W C Hui, et al.Nature Reviews. Clinical Oncology|October 8, 2025
Achieving control of nasopharyngeal carcinoma: the role of Epstein-Barr virus-based screening and vaccinesW K Jacky Lam, Brigette B Y Ma, Ann D King, et al.Nature Reviews. Clinical Oncology|July 1, 2021
Nasopharyngeal carcinoma: an evolving paradigmKenneth C W Wong, Edwin P Hui, Kwok-Wai Lo, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 20, 2020
Recent Advances in the Development of Biomarkers and Chemoradiotherapeutic Approaches for Nasopharyngeal CarcinomaBrigette B Y Ma, Yu-Pei Chen, Edwin P Hui, et al.Cancer|August 12, 2004
Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapyBrigette B Y Ma, Sing F Leungm, Edwin P Hui, et al.Investigational New Drugs|January 28, 2009
The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell linesBrigette B Y Ma, Fion Sung, Qian Tao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2026
Tumor-Agnostic Therapies: Translating Scientific Breakthroughs Into Global ImplementationJia Liu, Juliana Beal, Niamh Coleman, et al.Quantitative Imaging in Medicine and Surgery|September 3, 2021
A convolutional neural network combined with positional and textural attention for the fully automatic delineation of primary nasopharyngeal carcinoma on non-contrast-enhanced MRILun M Wong, Qi Yong H Ai, Darren M C Poon, et al.Investigational New Drugs|August 27, 2013
Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinomaChi Hang Wong, Herbert H Loong, Connie W C Hui, et al.Pageof 78